Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanne Vestergaard

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|December 8, 2011
Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemiaThomas Kristensen, Birgitte Preiss, Sigurd Broesby-Olsen, et al.
Expert Review of Hematology|June 4, 2015
Bone morbidity in chronic myeloproliferative neoplasmsSarah Farmer, Lukas Frans Ocias, Hanne Vestergaard, et al.
Acta Oncologica (Stockholm, Sweden)|January 20, 2016
Trends in hematological cancer in the elderly in Denmark, 1980-2012Lukas F Ocias, Thomas S Larsen, Hanne Vestergaard, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2013
KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosisSigurd Broesby-Olsen, Thomas Kristensen, Hanne Vestergaard, et al.
European Journal of Haematology|November 20, 2018
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasmsMette Brabrand, Knud Nørregaard Hansen, Christian B Laursen, et al.
International Journal of Hematology|August 13, 2015
Erratum to: Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markersSarah Farmer, Hanne Vestergaard, Stinus Hansen, et al.
Haematologica|January 16, 2014
A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosisChristen L Andersen, Nana B Mortensen, Tobias W Klausen, et al.
Acta Oncologica (Stockholm, Sweden)|March 25, 2021
Health-related quality of life of patients with haematologic cancer during COVID-19 and their opinions on telehealth consultations - a Danish single site cross-sectional surveyCharlotte Ellehuus, Stefan Starup Jeppesen, Lise Eckhoff, et al.
Leukemia & Lymphoma|May 10, 2018
Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-bloodThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 7, 2018
Venom anaphylaxis can mimic other serious conditions and disclose important underlying diseaseHenrik Fomsgaard Kjaer, Thomas Kristensen, Charlotte Gotthard Mortz, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|December 8, 2011
Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemiaThomas Kristensen, Birgitte Preiss, Sigurd Broesby-Olsen, et al.
Expert Review of Hematology|June 4, 2015
Bone morbidity in chronic myeloproliferative neoplasmsSarah Farmer, Lukas Frans Ocias, Hanne Vestergaard, et al.
Acta Oncologica (Stockholm, Sweden)|January 20, 2016
Trends in hematological cancer in the elderly in Denmark, 1980-2012Lukas F Ocias, Thomas S Larsen, Hanne Vestergaard, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2013
KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosisSigurd Broesby-Olsen, Thomas Kristensen, Hanne Vestergaard, et al.
European Journal of Haematology|November 20, 2018
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasmsMette Brabrand, Knud Nørregaard Hansen, Christian B Laursen, et al.
International Journal of Hematology|August 13, 2015
Erratum to: Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markersSarah Farmer, Hanne Vestergaard, Stinus Hansen, et al.
Haematologica|January 16, 2014
A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosisChristen L Andersen, Nana B Mortensen, Tobias W Klausen, et al.
Acta Oncologica (Stockholm, Sweden)|March 25, 2021
Health-related quality of life of patients with haematologic cancer during COVID-19 and their opinions on telehealth consultations - a Danish single site cross-sectional surveyCharlotte Ellehuus, Stefan Starup Jeppesen, Lise Eckhoff, et al.
Leukemia & Lymphoma|May 10, 2018
Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-bloodThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 7, 2018
Venom anaphylaxis can mimic other serious conditions and disclose important underlying diseaseHenrik Fomsgaard Kjaer, Thomas Kristensen, Charlotte Gotthard Mortz, et al.
Pageof 7